Foreword

Expert Rev Anticancer Ther. 2018 Oct;18(sup1):1. doi: 10.1080/14737140.2018.1516145.
No abstract available

Keywords: Relapsed ovarian cancer; non-platinum-based combination therapy; pegylated liposomal doxorubicin; sequence effect; trabectedin.

Publication types

  • Introductory Journal Article

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Female
  • Humans
  • Neoplasm Recurrence, Local
  • Ovarian Neoplasms / drug therapy*
  • Ovarian Neoplasms / pathology
  • Quality of Life